Goals of work Oral and systemic infections arising from the oral cavity are significant problems in clinical management of patients undergoing leukemia treatment. However,
Introduction
Acute myeloid leukemia (AML) is a heterogeneous clonal disorder of hematopoietic progenitor cells and is the most common type of malignant myeloid disorder in adults [1] . Treatment for AML consists of induction of chemotherapy and a number of cycles of consolidation chemotherapy. The goal of induction chemotherapy is to achieve complete remission by eliminating leukemic cells from the bone marrow. Consolidation chemotherapy is necessary to prevent relapse after remission. Each cycle of chemotherapy involves anti-cancer drug administration for 3-7 days, and recovery from neutropenia and thrombocytopenia requires about 2-3 weeks. Hematopoietic cell transplantation (HCT) can be used as post-remission therapy [3] .
Oral and systemic infections arising from the oral cavity are significant problems in the clinical management of cancer patients treated with intensive chemotherapy regimens, including HCT [4] . Periodontitis is a chronic inflammatory disease, affecting the deeper parts of the periodontium. As dental plaque migrates subgingivally in the apical direction of the tooth root, the periodontal attachment apparatus is degraded, leading to the formation of periodontal pockets and resulting inflammatory resorption of alveolar bone. A considerable amount of ulcerated pocket epithelium (up to 35 cm 2 ) may be present in severe, untreated periodontitis. Patients with periodontitis harbor periodontal pathogens, many of which are gram-negative facultatively anaerobic bacteria [10] . There is evidence that pre-existing periodontal infections may induce fever and that microorganisms may spread systemically [2, 5, 7, 9] . The risk of developing systemic infections may be associated with the severity of periodontal disease (i.e., the total surface area of the ulcerated pocket epithelium) and the composition of the subgingival microflora [10] . Nevertheless, the harmful influences of gingivitis and periodontitis on systemic infection in neutropenic cancer patients are largely unknown [10] . Cross-sectional studies of patients receiving immunosuppressive drugs failed to show differences in the prevalence or severity of periodontitis between transplantation patients and healthy controls [12, 13] . Evidence reported to date has been limited to findings indicating the systemic influence of periodontal infection in neutropenic patients.
The present study indicated an association between febrile neutropenia and periodontitis in a case in which periodontal treatment in the intervals between chemotherapy cycles reduced febrile neutropenia in subsequent courses of chemotherapy and HCT. These observations suggest the importance of periodontal treatment in such patients to prevent febrile neutropenia.
Materials and methods

Patient
The patient was a 61-year-old Japanese man who developed acute myeloid leukemia (AML) and was referred to the Department of Hematology, Okayama University Hospital of Medicine and Dentistry. Before leukemia treatment, he was referred to the Department of Periodontics and Endodontics for oral examination and treatment, if necessary, by his physician. The patient's medical history was unremarkable except for the leukemia.
Clinical oral findings on first visit
The first oral examination was performed on the first day of induction chemotherapy. Generally, periodontitis is diagnosed by measuring pocket depths and loss of attachment using a periodontal probe supplemented by radiographs [10] . The radiographic and gingival appearances in this case are shown in Fig. 1a -c. The patient had advanced chronic periodontitis. Among almost all teeth, loss of 1/3-1/2 adjacent supporting bone was observed corresponding to advanced deep periodontal pockets ranging from 4 to 6 mm, the normal range of which is under 3 mm. Periodontitis was especially advanced locally at the right upper incisor. Supporting bone loss reached the root apex (Fig. 1c) . This patient was diagnosed as being at high risk of developing systemic infection from periodontitis. On the other hand, redness of the gingiva was not remarkable despite advanced periodontitis, probably because his neutrophil count was low.
Periodontal treatment
This patient received HCT following a total of three cycles of chemotherapy. After recovery from neutropenia induced by initial chemotherapy, periodontal treatment was performed in each interval period of chemotherapy. Following extraction of teeth with severe advanced periodontitis, periodontal pocket curettage and root planing, which are common periodontal treatments to reduce periodontal pockets harboring anaerobic periodontal bacteria, was performed for all teeth before HCT. Mean periodontal pocket depths measured for 6 points around all remaining teeth before and after periodontal treatment were examined.
Examination of febrile neutropenia
The numbers of days of febrile neutropenia in each course of chemotherapy and HCT were examined. Febrile neutropenia was defined according to Masaoka's description [6] as follows:
1. Fever: single axillary temperature of 37.5°C 2. Neutropenia: neutrophil count less than 1,000 cells/μl
Statistical analysis
Periodontal pockets were compared before and after periodontal treatment by χ 2 test. The numbers of days of febrile neutropenia in each course of chemotherapy and HCT were Fig. 1 Radiographic and gingival appearance on first visit. a Gingival appearance on first visit. Deep advanced periodontal pockets with probing depths ranging from 4 to 6 mm were detected among almost all teeth. Redness of the gingiva was not remarkable, probably because neutrophil count was low. Especially in the right upper incisor tooth, extremely deep pockets reached the root apex. b Radiographic appearance on first visit. Among almost all teeth, loss of 1/3-1/2 of the adjacent supporting bone and calculus were observed. c Enlargement of radiographic appearance in the right upper incisor tooth region. Supporting bone loss reached the root apex also compared by χ 2 test. P-values were calculated using the statistical software StatFlex (Artech, Osaka, Japan).
Results
Clinical course
The patient's medical and dental treatment as well as neutrophil counts and fever are shown in Figs. 2, 4, 5, and 6. Detailed clinical courses were as follows.
During induction chemotherapy
As the patient's first visit was the first day of induction chemotherapy and his general condition did not allow postponement of the start of chemotherapy, no invasive periodontal treatment was planned until completion of induction chemotherapy. The clinical course is shown in Fig. 2 . Induction chemotherapy was performed with the anti-cancer drugs cytarabine (cytosine arabinoside; Ara-C) and daunorubicin (DNR) for 7 and 3 days, respectively. Febrile neutropenia occurred from day 1 to day 10 and from day 18 to day 19. As the patient had no fever during consolidation chemotherapy with Ara-C, infection and not the drug itself was suspected to be the cause of fever. Elevation of fever in this period mostly corresponded to the development of inflammatory signs in the right upper incisor tooth region and in the upper left molar, while Fig. 2 Summary of patient's medical and dental treatment and clinical courses of neutrophil counts and fever in induction chemotherapy. The gray zone shows the neutropenic period (neutrophil counts <1,000/μl). Abbreviations are as follows, antibiotics: CFPM cefepime, MEPM meropenem, PZFX pazufloxacin, VCM vancomycin, IPM/CS imipenem/cilastatin, TEIC teicoplanin, FMOX flomoxef, CFPM cefepime, LVFX levofloxacin, CPFX ciprofloxacin. Anti-cancer drugs: DNR daunorubicin, Ara-C cytosine arabinoside. Tooth position and dental treatments:
right upper incisor, ext tooth extraction, P-cur periodontal pocket curettage, left upper molars Fig. 3 Gingival appearance at the right upper incisor tooth region during induction chemotherapy. Swelling, tenderness, and fistula appeared in the right upper incisor tooth region. On the other hand, these symptoms were relatively weak for systemic symptoms (high fever). Furthermore, the amount of exudate from the fistula was small, and it was clear rather than white in color. These features were possibly because the neutrophil count was low Fig. 4 Summary of patient's medical and dental treatment and clinical courses of neutrophil counts and fever in the first consolidation chemotherapy. The gray zone shows the neutropenic period (neutrophil counts <1,000/μl). Abbreviations are as follows, antibiotics: CFPM cefepime, MEPM meropenem, CPFX ciprofloxacin. Anticancer drugs: MIT mitoxantrone, Ara-C cytosine arabinoside. Tooth position and dental treatments: left upper molars, P-cur periodontal pocket curettage, left upper second molar phlegm production increased in a few days. The results of culture of the pus from the first right upper incisor gingival were negative and oral normal flora on two separate occasions. When phlegm production increased, no bacteria except oral normal flora were detected on phlegm culture. Chest radiography did not show bacterial pneumonic images. Blood test for β-D-glucan was negative. All results of blood culture were negative although examinations were performed on 8 days (eight sets of 16 samples; blood culture was performed using paired samples collected from different points) during induction chemotherapy. Indications of infection were limited to fever and visible signs. Interestingly, when fever was high and no obvious infection was detected other than periodontal infection, the development of inflammatory signs at the right upper incisor gingiva region was relatively weak, while swelling, tenderness, and a fistula were obvious (Fig. 3) . The amount of exudate from the fistula was small, and it was clear rather than white in color. There were no visible changes in the upper left molar gingiva despite the patient's complaint. These features were probably because neutrophil count was low.
Not only local treatment for periodontitis, such as pocket irrigation with 0.2% povidone iodine and local application of minocycline ointment (Periocline®; Sunstar Inc., Osaka, Japan), but also systemic antibiotic treatment was performed as shown in Fig. 2 . Antibiotics were used throughout the neutropenic period (neutrophils<1,000/μl), and a total of six types of antibiotic were used in this period of 26 days, as shown in Fig. 2 . Systemic antibiotics were given as treatment against conventional febrile neutropenia, because no direct microbiological evidence related to periodontitis could be obtained, while the possibility of involvement of periodontal anaerobic bacteria remained.
Interval between induction chemotherapy and the first consolidation chemotherapy
The clinical course is shown in Fig. 2 . On consultation with the physician, the right upper incisor tooth, which suffered severe periodontitis and was suspected as the main cause of infection during induction chemotherapy, was extracted during this period of recovery from neutropenia and thrombocytopenia. Following tooth extraction, periodontal pocket curettage and root planing, which are common periodontal treatments used to reduce periodontal pockets harboring anaerobic periodontal bacteria, were performed for the left upper and lower teeth. This resulted in elevation of fever for several days beyond our expectations despite use of antibiotics. To avoid delaying the start of the next course of chemotherapy by dental treatment, periodontal pocket curettage of the right side was postponed.
During the first consolidation chemotherapy and the interval between the first and second courses of consolidation chemotherapy
The clinical course is shown in Fig. 4 . The first course of consolidation chemotherapy was performed with the anti-cancer drugs Ara-C and mitoxantrone (MIT) for 5 and 3 days, respectively. Febrile neutropenia occurred for only 3 days from day 17 to day 19, and was decreased significantly as compared with that during induction chemotherapy ( Table 1 ). The doses of antibiotics used in this period were also decreased. Intravenous hyperalimentation (IVH) catheter infection was suspected, because the skin around the injection point showed redness, while no pus was observed and culture results of the catheter were negative. Following removal of the IVH catheter, periodontitis in the left upper molar region remained despite periodontal pocket curettage and root planing and was suspected as the causes of infection. All of the results of blood culture (two sets of four samples) were negative. Periodontal examination after recovery from the neutropenic condition revealed remaining progressive periodontal pockets in the upper left molar gingiva. Further periodontal pocket curettage and root planing of this region and of the right upper and lower teeth were performed.
During the second course of consolidation chemotherapy and the interval between the second course of consolidation chemotherapy and HCT
The clinical course is shown in Fig. 5 . The second course of consolidation chemotherapy was performed with the anti-cancer drugs Ara-C and DNR for 5 and 3 days, respectively. Febrile neutropenia occurred for only 5 days from day 15 to day 19. The suspected causes of the 5 days of high fever were pharyngitis for the former 3 days, because of throat pain and redness, although no bacteria except for oral normal flora were detected in two pharyngeal cultures and gingivitis for the latter 2 days. All of the results of blood culture (two sets of four samples) were negative. The antibiotics used in this period were as shown in Fig. 5 .
Periodontal examination was performed after recovery from the neutropenic condition. At this point, periodontal pocket depths ranged from 3-4 mm in almost all teeth.
During HCT
HCT was performed with a reduced-intensity regimen as shown in Fig. 6 . High-dose chemotherapy was performed from 8 days before HCT. After HCT, 17 days were taken for engraftment. No febrile neutropenia occurred. The only antibiotic used in this period was cefepime administered for 6 days to treat oral mucositis induced by anti-cancer drugs (days 9-14).
Number of days of febrile neutropenia in each chemotherapy and HCT period according to the progress of periodontal treatment
The numbers of days of febrile neutropenia in each chemotherapy and HCT period are shown with the progress of periodontal treatment in Table 1 . Mean periodontal pocket depths measured for six points around all remaining teeth before and after periodontal treatment are also shown. Periodontal treatment successfully reduced periodontal pockets from 4.1±1.5 to 3.0±0.6 mm, which was almost within the healthy range (<3.0 mm). The frequency of febrile neutropenia decreased with increasing cycles of chemotherapy, and decreases in febrile neutropenia corresponded to the progress of periodontal treatment.
Discussion
The clinical courses of patients developing periodontal infection without the occurrence of other infections provide valuable information to determine the effects of periodontal infection in compromised patients undergoing leukemia treatment. However, such cases are rare because the severe compromised condition results in many types of infection. Furthermore, bacteremia is not always present or detectable. Indeed, all results of bacterial detections (twice for detection in pus from the first right upper incisor gingival and a total of 12 trials of blood culture) were negative in this case. This difficulty in microbiological detection may mask evidence of an association between febrile neutropenia and periodontitis. In addition, almost all periodontal pathogens are anaerobes, and this probably makes detection difficult. Therefore, this association was suggested based on the decrease in febrile neutropenia with progress of successful periodontal treatment seen in the detailed clinical course.
The case reported here can be summarized as follows: (1) symptoms speculated as development of periodontitis were almost always observed when fever was elevated; (2) periodontal infection attracted attention as the main source of infection in most periods of elevated fever by both physicians and dentists, and the involvement of other infections in fever elevation was considered relatively low; and (3) the number of days of febrile neutropenia in each course of chemotherapy decreased with the progress of periodontal treatment in the chemotherapy interval. Thus, the influence of periodontal infection and its treatment in compromised patients undergoing leukemia treatment was indicated.
Dentists generally recognize the importance of periodontal treatment in patients with hematological malignancies. However, the relative contributions of gingivitis and periodontitis to systemic infection in neutropenic cancer patients are largely unknown [10] . The incidence of socalled acute periodontal infections in previous studies showed significant disparity [10] . For example, 28% of all clinically defined infections in 22 leukemia patients that developed neutropenic fever during remission induction therapy were reported to be periodontitis [7] . However, in subsequent investigations, acute periodontal infections either did not develop at all [8, 11] or only very infrequently [13] . Our experience in removing periodontal infection in such compromised patients indicated that it is also difficult to predict the development of periodontitis, because even severe periodontitis is not necessarily caused by acute periodontal infection. However, in the present case, elevated fever was strongly suspected to be induced by severe periodontitis, and the number of days of febrile neutropenia in each course of chemotherapy decreased with the progress of periodontal treatment. Finally, no febrile neutropenia occurred during HCT. These observations indicated the importance of periodontal treatment in such patients. We would like to emphasize that periodontitis could cause febrile neutropenia, and successful periodontal treatment probably reduced febrile neutropenia.
Periodontal treatment during the chemotherapy interval may not only reduce the risk of systemic infection, but also lead to a decrease in antibiotic use as in the present case. Therefore, periodontal treatment is medically economical. In addition, reducing the use of antibiotics may contribute to prevention of the appearance of antibiotic-resistant bacteria. Naturally, the development of odontogenic infection itself during the neutropenic period is dangerous. On the other hand, for neutropenic patients undergoing HCT, the worst type of life-threatening bacterial infection is that by multi-drug-resistant bacteria. Periodontal treatment that can reduce the use of antibiotics may contribute to infection control not only by preventing the development of periodontitis itself, but also by reducing the likelihood of the appearance of antibiotic-resistant bacteria.
In conclusion, the results of the present study indicated an association between febrile neutropenia and periodontitis in a case in which periodontal treatment in the intervals between chemotherapy cycles reduced febrile neutropenia in subsequent courses of chemotherapy and HCT. The nature of this case and lack of direct bacterial evidence (culture results did not show a direct association between bacteremia and periodontitis) make this association presumptive. However, the observations reported here indicate the importance of periodontal treatment in clinical management of patients undergoing leukemia treatment to prevent febrile neutropenia.
